Xi Yang

Dr. Xi Yang

orcid

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
Verified
Journal Article
Open access
PDF file
XYXi Yang
Xi Yang
HNHannah L Nathan
Hannah L Nathan
EOEbruba Ese Oyekan
Ebruba Ese Oyekan
TKTim I. M. Korevaar
Tim I. M. Korevaar
DADoaa Ibrahim Mohamed Ahmed
Doaa Ibrahim Mohamed Ahmed
COCaroline Ovadia
Caroline Ovadia
Objectives: We aimed to develop and validate a simple, easy-to-use risk stratification tool to use in the diagnosis of gestational diabetes mellitus (GDM) to triage those more likely to require insulin treatment. Methods: Using an audit of patients with GDM in 2019, multivariable logistic regression was used to select variables and develop a prediction model for insulin requirement. A stratification tool was developed by dichotomising these selected variables; its performance was assessed with an internal cohort from 2021 and externally from patients managed at a separate hospital. Results: Patients with a higher fasting blood glucose concentration (OR 2.41, 95% CI 1.84–3.15) and higher booking body mass index (OR 1.48, 95% CI 1.07–2.03) were more likely to require insulin therapy whilst a later gestational-weeks-at-diagnosis value gave a lower risk of insulin therapy (OR 0.71, 95% CI 0.62–0.81 per week). The low-risk group for insulin requirement was defined thus: fasting blood glucose < 5.6 mmol/L, booking BMI < 30 kg/m2, and gestational weeks at diagnosis ≥ 24 weeks. This classification had a negative predictive value (NPV) of 94% for insulin requirement, with a sensitivity of 84% and specificity of 56% in the development cohort. Similarly, in the internal and external validation cohorts, the NPVs were 93 and 90%, with sensitivity values of 77 and 78%, respectively. Conclusions: This study developed a pragmatic tool with three criteria for stratifying the GDM group not requiring insulin treatment, with successful validation for clinical use.

21 July 2025 in European Journal of Obstetrics & Gynecology and Reproductive Biology
Verified
Journal Article
Open access
XYXi Yang
Xi Yang
NWNicholas J. Williamson
Nicholas J. Williamson
JSJenna Sajous
Jenna Sajous
AMAlice L. Mitchell
Alice L. Mitchell
JCJenny Chambers
Jenny Chambers
COCaroline Ovadia
Caroline Ovadia
Pruritus is a common symptom of intrahepatic cholestasis of pregnancy (ICP), yet its relationship with hypercholanaemia and progression across gestation remains unclear. 139 participants (1997-2020) recruited from nine UK hospitals and ICP Support. Maternal characteristics and serial serum measurements were collected. Pruritus severity was categorized into five levels. Multiple logistic regression was used to evaluate factors associated with pruritus deterioration. Among 139 women, 53 % (61/115) experienced pruritus deterioration. ALT and bilirubin were not significantly associated with severity progression. However, bile acid concentration (OR 2.36, 95 % CI 1.22-4.56) and maternal BMI (OR 2.40, 95 % CI 1.20-4.81) were independent risk factors. A higher risk of pruritus severity deterioration was found in those with peak bile acid concentrations ≥ 100 µmol/L (OR 7.45, 95 %CI 1.43-38.86, p = 0.02). Higher peak bile acid concentrations and maternal BMI are associated with worsening pruritus severity in ICP.